Sona Nanotech Inc. (SONA.CN)
CAD 0.27
(-1.82%)
CAD 0.27
(-1.82%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.43 Million CAD | -22.47% |
| 2022 | 3.13 Million CAD | -70.78% |
| 2021 | 10.73 Million CAD | 78.59% |
| 2020 | 6 Million CAD | 245.77% |
| 2019 | 1.73 Million CAD | -66.76% |
| 2018 | 5.22 Million CAD | 1361.36% |
| 2017 | 357.72 Thousand CAD | -29.88% |
| 2016 | 510.14 Thousand CAD | -7.65% |
| 2015 | 552.38 Thousand CAD | 10.0% |
| 2014 | 502.17 Thousand CAD | -19.6% |
| 2013 | 624.61 Thousand CAD | -34.56% |
| 2012 | 954.54 Thousand CAD | 9.86% |
| 2011 | 868.84 Thousand CAD | 14.98% |
| 2010 | 755.65 Thousand CAD | -11.29% |
| 2009 | 851.8 Thousand CAD | -69.0% |
| 2008 | 2.74 Million CAD | 108.01% |
| 2007 | 1.32 Million CAD | 417.65% |
| 2006 | 255.19 Thousand CAD | 7102.68% |
| 2005 | 3543.00 CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 711.6 Thousand CAD | -11.38% |
| 2024 Q2 | 595.04 Thousand CAD | 5.9% |
| 2024 Q1 | 561.89 Thousand CAD | -25.45% |
| 2023 Q2 | 503.32 Thousand CAD | 34.36% |
| 2023 Q1 | 374.61 Thousand CAD | 156.65% |
| 2023 FY | 2.38 Million CAD | -24.1% |
| 2023 Q4 | 753.65 Thousand CAD | -12.2% |
| 2023 Q3 | 858.35 Thousand CAD | 70.54% |
| 2022 Q4 | -661.32 Thousand CAD | -169.01% |
| 2022 FY | 3.13 Million CAD | -70.78% |
| 2022 Q1 | 1.51 Million CAD | -11.09% |
| 2022 Q2 | 1.32 Million CAD | -12.16% |
| 2022 Q3 | 958.24 Thousand CAD | -27.83% |
| 2021 Q1 | 3.73 Million CAD | 8.12% |
| 2021 Q2 | 3.14 Million CAD | -15.73% |
| 2021 Q3 | 2.15 Million CAD | -31.39% |
| 2021 FY | 10.73 Million CAD | 78.59% |
| 2021 Q4 | 1.69 Million CAD | -21.19% |
| 2020 Q3 | 1.72 Million CAD | 225.81% |
| 2020 Q4 | 3.45 Million CAD | 100.33% |
| 2020 Q2 | 528.65 Thousand CAD | 71.91% |
| 2020 Q1 | 307.52 Thousand CAD | -29.15% |
| 2020 FY | 6 Million CAD | 245.77% |
| 2019 Q2 | 469.17 Thousand CAD | 29.68% |
| 2019 FY | 1.73 Million CAD | -66.76% |
| 2019 Q1 | 361.79 Thousand CAD | -92.48% |
| 2019 Q3 | 465.85 Thousand CAD | -0.71% |
| 2019 Q4 | 434.05 Thousand CAD | -6.83% |
| 2018 Q3 | 145.75 Thousand CAD | -4.5% |
| 2018 Q1 | 121.19 Thousand CAD | 42.21% |
| 2018 FY | 5.22 Million CAD | 1361.36% |
| 2018 Q4 | 4.8 Million CAD | 3198.71% |
| 2018 Q2 | 152.62 Thousand CAD | 25.93% |
| 2017 Q2 | 85.52 Thousand CAD | -13.56% |
| 2017 FY | 357.72 Thousand CAD | -29.88% |
| 2017 Q4 | 85.22 Thousand CAD | -3.19% |
| 2017 Q3 | 88.03 Thousand CAD | 2.93% |
| 2017 Q1 | 98.94 Thousand CAD | -33.57% |
| 2016 Q2 | 120.54 Thousand CAD | -7.19% |
| 2016 FY | 510.14 Thousand CAD | -7.65% |
| 2016 Q3 | 110.76 Thousand CAD | -8.12% |
| 2016 Q4 | 148.95 Thousand CAD | 34.48% |
| 2016 Q1 | 129.88 Thousand CAD | -6.57% |
| 2015 Q3 | 144.03 Thousand CAD | 1.02% |
| 2015 Q2 | 142.58 Thousand CAD | 12.5% |
| 2015 Q1 | 126.74 Thousand CAD | -17.71% |
| 2015 FY | 552.38 Thousand CAD | 10.0% |
| 2015 Q4 | 139.01 Thousand CAD | -3.49% |
| 2014 Q4 | 154.01 Thousand CAD | 31.01% |
| 2014 Q3 | 117.56 Thousand CAD | 8.56% |
| 2014 Q2 | 108.29 Thousand CAD | -11.46% |
| 2014 FY | 502.17 Thousand CAD | -19.6% |
| 2014 Q1 | 122.3 Thousand CAD | -8.94% |
| 2013 Q3 | 164.35 Thousand CAD | -1.92% |
| 2013 FY | 624.61 Thousand CAD | -34.56% |
| 2013 Q2 | 167.57 Thousand CAD | 5.81% |
| 2013 Q4 | 134.31 Thousand CAD | -18.27% |
| 2013 Q1 | 158.37 Thousand CAD | -15.36% |
| 2012 Q1 | 294.68 Thousand CAD | 29.26% |
| 2012 FY | 954.54 Thousand CAD | 9.86% |
| 2012 Q4 | 187.12 Thousand CAD | 11.75% |
| 2012 Q3 | 167.45 Thousand CAD | -54.32% |
| 2012 Q2 | 366.56 Thousand CAD | 24.39% |
| 2011 FY | 868.84 Thousand CAD | 14.98% |
| 2011 Q2 | 212.37 Thousand CAD | 2.85% |
| 2011 Q1 | 206.48 Thousand CAD | 21.22% |
| 2011 Q3 | 222.01 Thousand CAD | 4.54% |
| 2011 Q4 | 227.96 Thousand CAD | 2.68% |
| 2010 Q2 | 211.47 Thousand CAD | 1.61% |
| 2010 Q1 | 208.13 Thousand CAD | -9.79% |
| 2010 Q4 | 170.34 Thousand CAD | 2.8% |
| 2010 Q3 | 165.7 Thousand CAD | -21.65% |
| 2010 FY | 755.65 Thousand CAD | -11.29% |
| 2009 Q1 | 233.14 Thousand CAD | -63.45% |
| 2009 FY | 851.8 Thousand CAD | -69.0% |
| 2009 Q2 | 223.31 Thousand CAD | -4.21% |
| 2009 Q4 | 230.72 Thousand CAD | 40.14% |
| 2009 Q3 | 164.63 Thousand CAD | -26.28% |
| 2008 Q2 | 1.33 Million CAD | 431.14% |
| 2008 Q4 | 637.85 Thousand CAD | 21.69% |
| 2008 Q3 | 524.14 Thousand CAD | -60.73% |
| 2008 FY | 2.74 Million CAD | 108.01% |
| 2008 Q1 | 251.29 Thousand CAD | -53.08% |
| 2007 Q4 | 535.58 Thousand CAD | 60.74% |
| 2007 Q3 | 333.19 Thousand CAD | 7.86% |
| 2007 Q2 | 308.92 Thousand CAD | 115.61% |
| 2007 Q1 | 143.27 Thousand CAD | 30.07% |
| 2007 FY | 1.32 Million CAD | 417.65% |
| 2006 FY | 255.19 Thousand CAD | 7102.68% |
| 2006 Q2 | 93.35 Thousand CAD | 217009.3% |
| 2006 Q4 | 110.15 Thousand CAD | 111.66% |
| 2006 Q3 | 52.04 Thousand CAD | -44.25% |
| 2006 Q1 | 43.00 CAD | 0.0% |
| 2005 FY | 3543.00 CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| BioMark Diagnostics Inc. | 1.47 Million CAD | -64.401% |
| Izotropic Corporation | 1.56 Million CAD | -55.226% |